Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.
about
Antiviral perspectives for chikungunya virusThe global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictusExtended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine CandidateDevelopment of Neutralization Assay Using an eGFP Chikungunya VirusChikungunya vaccines in developmentThe Global Virus Network: Challenging chikungunyaNonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus InfectivityA chikungunya fever vaccine utilizing an insect-specific virus platformChikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.Development of Vaccines for Chikungunya Fever.Animal Models of Chikungunya Virus Infection and Disease.Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness.A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.A novel live-attenuated vaccine candidate for mayaro Fever.Real-time monitoring of disease progression in rhesus macaques infected with Borrelia turicatae by tick bite.Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.Do we need a vaccine against chikungunya?Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activationAttenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.Self-replicating alphavirus RNA vaccines.Protective and Pathogenic Responses to Chikungunya Virus Infection.Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.Recent progress on chikungunya virus research.Vaccine and Therapeutic Options To Control Chikungunya Virus.Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.Cellular and Molecular Immune Response to Chikungunya Virus Infection
P2860
Q21284682-11099C41-D7AA-4268-8E18-A650028B333CQ22680660-7123071A-E38F-4C19-A744-66B99D46788EQ24276430-9BAD5BEA-8C92-473C-8BA3-F67F24CBBD0AQ26314416-2E9A146A-CE16-4821-ABC8-08A994783EC3Q26700081-177AFE4B-0D01-4159-8340-79075C6B94D5Q26700155-CC90621D-126C-40CA-9830-3C5631B47D92Q26782722-B47D1307-4081-40C1-8508-63DBB2724687Q28550385-1205FDD7-6CA2-4D65-9B7F-2E214A888FCAQ28954709-D7B63A8C-1227-4FFF-BF62-7F7C1C988EE2Q30235512-CCA0E14A-4211-49E6-8BB4-7B8C4B0098D8Q30240191-017194E8-1271-4C62-A549-B9C508E5B764Q30240216-FDA41E53-3E53-4306-9745-1B27D96C16B8Q33907676-D919ADF8-3597-4BCC-A305-ED5002E3BA4FQ33945612-3D0132E6-935C-442E-8AC4-49977870A091Q34015300-EC80A1E2-C522-446C-A42B-FAA213B1A538Q35078565-847F0A65-7E83-4EDE-9825-79141F7B9673Q35229553-BEF1149E-AC15-4C8C-B8AE-532CC8C4913DQ35581782-E2AA508F-A90E-4590-953A-5C6E5F7085FEQ35675871-83678DA9-49C2-4B8C-A2E1-2E0B28A42304Q35933249-65D5CDFD-BA86-49A2-A8EF-C936E43FC5D5Q36665279-CB6C4B44-9059-4E94-8508-1DA2F5C42AB0Q37711813-CF96F45E-741F-4E66-98D5-1A90AB74B48AQ38255634-6710A113-CBD0-408E-AA36-24903AF6E454Q38586243-7A8E97A0-29C3-42E4-8C73-43FF84D330D4Q40077678-ECFAEBDA-88E9-4B19-B7B5-918D499B1D89Q44843482-DD3C3099-6516-4EC6-9B9D-21AC2F102C79Q47566099-BBD6B949-1584-4D92-A07C-7EDCD9AA9076Q52671193-D2FBA85A-1115-4ED4-AE3B-FADC9E100126Q58575620-B967ACB1-F8EC-426F-A21D-F0793B1FDD0D
P2860
Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chikungunya vaccine candidate ...... sease following a single dose.
@ast
Chikungunya vaccine candidate ...... sease following a single dose.
@en
type
label
Chikungunya vaccine candidate ...... sease following a single dose.
@ast
Chikungunya vaccine candidate ...... sease following a single dose.
@en
prefLabel
Chikungunya vaccine candidate ...... sease following a single dose.
@ast
Chikungunya vaccine candidate ...... sease following a single dose.
@en
P2093
P2860
P356
P1476
Chikungunya vaccine candidate ...... isease following a single dose
@en
P2093
A Paige Adams
Heather Vinet-Oliphant
Kenneth Plante
Robert L Seymour
Rodion Gorchakov
P2860
P304
P356
10.1093/INFDIS/JIU014
P407
P5008
P577
2014-01-07T00:00:00Z